(Q37195389)

18 August 2017

1 reference

title

Autologous haematopoietic stem-cell transplantation in multiple sclerosis (English)

1 reference

stem cell transplantation

18 August 2017

0 references

1 reference

Gianluigi Mancardi

1

1 reference

PubMed ID

18565456

18 August 2017

Riccardo Saccardi

series ordinal

2

1 reference

18 August 2017

1 July 2008

1 reference

18 August 2017

1 reference

18 August 2017

7

1 reference

18 August 2017

7

1 reference

18 August 2017

626-636

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

18 August 2017

1 reference

7 January 2021

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Survival, and time to an advanced disease state or progression, of untreated patients with moderately severe multiple sclerosis in a multicenter observational database: relevance for design of a clinical trial for high dose immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Rationale for bone marrow transplantation in the treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Regression of adjuvant-induced arthritis in rats following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Infusion of marrow and spleen cells in irradiated NZB-Bl mice: amelioration of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Stem cell transplantation for autoimmune disorders. Preclinical experiments

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Bone marrow transplantation for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Treatment of severe autoimmune disease by stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, M

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Failure of allogeneic bone marrow transplantation to arrest disease activity in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous peripheral blood stem cell transplantation for severe multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous hematopoietic stem cell transplantation for progressive multiple sclerosis: report of efficacy and safety at three yr of follow up in 21 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous hematopoietic stem cell transplantation for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Clinical exacerbation of multiple sclerosis following radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Immunoablative therapy as a treatment aggressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Bone marrow transplantation: does it stop MS progression?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Stem cell transplantation for multiple sclerosis: What is the evidence?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Hematopoietic stem cell transplantation for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous Stem Cell Transplantation for Severe Autoimmune Diseases: A 10-Year Experience

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous haematopoietic-stem-cell transplantation for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

The Uhthoff phenomenon: a potential post transplant complication in advanced progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Acquired hemophilia-A in a patient with multiple sclerosis treated with autologous hematopoietic stem cell transplantation and interferon beta-1a

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Is haematopoietic stem cell transplantation a treatment option for severe MS or not?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous HSCT for advanced MS: Is the glass half-empty or really half-full?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

A Three-Year Study of Brain Atrophy after Autologous Hematopoietic Stem Cell Transplantation in Rapidly Evolving Secondary Progressive Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Tolerance induction by bone marrow transplantation in a multiple sclerosis model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Bone-marrow transplantation fails to halt intrathecal lymphocyte activation in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Changes of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) after autologous hematopoietic stem cell transplantation in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Transplanted bone marrow generates new neurons in human brains

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

From marrow to brain: expression of neuronal phenotypes in adult mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Little evidence for developmental plasticity of adult hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Failure of bone marrow cells to transdifferentiate into neural cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Emerging therapies for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Stem cell transplantation in multiple sclerosis: safety and ethics.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Hematopoietic stem cell transplantation in autoimmune diseases: is the glass half full or half empty?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

Will hematopoietic stem cell transplantation cure human autoimmune diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970138-8

7 January 2021

10.1016/S1474-4422(08)70138-8

Identifiers

DOI

1 reference

release_3rhf34j3h5d7loue46o2bonqb4

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3rhf34j3h5d7loue46o2bonqb4

24 November 2022

mapped directly with Wikidata item

PubMed ID

18565456

1 reference

PubMed ID

18565456